A novel in vitro filter trap assay identifies tannic acid as an amyloid aggregation inducer for HET-s

Journal of Biotechnology

Volumn 125, Issue 2, 2006, Pages 222-230

  Boyé Harnasch, Mona ^a   Cullin, Christophe ^a  

^a Institut de Biochimie et Genetique Cellulaires   (France)

Author keywords

Amyloid; Filter trap assay; HET s; Prion; Tannic acid

Indexed keywords

AGGLOMERATION; BIOASSAY; CHEMICAL COMPOUNDS; COST EFFECTIVENESS; FIBERS; FILTERS (FOR FLUIDS); FLUORESCENCE; PROTEINS;

AMYLOID FIBRE FORMATION; EPIGALLOCATECHIN-GALLATE; PRION PROTEIN; TANNIC ACID;

CARBOXYLIC ACIDS;

AMYLOID PROTEIN; CELLULOSE ACETATE; CHEMICAL COMPOUND; EPIGALLOCATECHIN; PRION PROTEIN; PROTEINASE K; TANNIN; ZINC CHLORIDE;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE; IN VITRO STUDY; NONHUMAN; PODOSPORA ANSERINA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DOMAIN;

AMYLOID; BIOTECHNOLOGY; ENDOPEPTIDASE K; FUNGAL PROTEINS; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; PODOSPORA; PRIONS; RECOMBINANT PROTEINS; TANNINS;

PODOSPORA ANSERINA;

EID: 33747056003     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2006.03.006     Document Type: Article

References (28)

1. Bach S., Talarek N., Andrieu T., Vierfond J.M., Mettey Y., Galons H., Dormont D., Meijer L., Cullin C., and Blondel M. Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat. Biotechnol. 21 9 (2003) 1075-1081
2. Balguerie A., Dos Reis S., Coulary-Salin B., Chaignepain S., Sabourin M., Schmitter J.M., and Saupe S.J. The sequences appended to the amyloid core region of the HET-s prion protein determine higher-order aggregate organization in vivo. J. Cell. Sci. 117 Pt 12 (2004) 2599-2610
3. Baskakov I.V., and Bocharova O.V. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features. Biochemistry 44 7 (2005) 2339-2348
4. Bocharova O.V., Breydo L., Parfenov A.S., Salnikov V.V., and Baskakov I.V. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J. Mol. Biol. 346 2 (2005) 645-659
5. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., and Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 6880 (2002) 507-511
6. Caughey B., Raymond G.J., Priola S.A., Kocisko D.A., Race R.E., Bessen R.A., Lansbury Jr. P.T., and Chesebro B. Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update. Mol. Biotechnol. 13 1 (1999) 45-55
7. Caughey B., Raymond L.D., Raymond G.J., Maxson L., Silveira J., and Baron G.S. Inhibition of protease-resistant prion protein accumulation in vitro by curcumin. J. Virol. 77 9 (2003) 5499-5502
8. DeMarco M.L., and Daggett V. From conversion to aggregation: protofibril formation of the prion protein. Proc. Natl. Acad. Sci. U.S.A. 101 8 (2004) 2293-2298
9. Dos Reis S., Coulary-Salin B., Forge V., Lascu I., Begueret J., and Saupe S.J. The HET-s prion protein of the filamentous fungus Podospora anserine aggregates in vitro into amyloid-like fibrils. J. Biol. Chem. 277 8 (2002) 5703-5706
10. Grimminger V., Richter K., Imhof A., Buchner J., and Walter S. The prion curing agent guanidinium chloride specifically inhibits ATP hydrolysis by Hsp104. J. Biol. Chem. 279 9 (2004) 7378-7383
11. Heijmen F.H., du Pont J.S., Middelkoop E., Kreis R.W., and Hoekstra M.J. Cross-linking of dermal sheep collagen with tannic acid. Biomaterials 18 10 (1997) 749-754
12. Heiser V., Scherzinger E., Boeddrich A., Nordhoff E., Lurz R., Schugardt N., Lehrach H., and Wanker E.E. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy. Proc. Natl. Acad. Sci. U.S.A. 97 12 (2000) 6739-6744
13. Jung G., and Masison D.C. Guanidine hydrochloride inhibits Hsp104 activity in vivo: a possible explanation for its effect in curing yeast prions. Curr. Microbiol. 43 1 (2001) 7-10
14. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 5618 (2003) 486-489
15. Khan N.S., Ahmad A., and Hadi S.M. Anti-oxidant, pro-oxidant properties of tannic acid and its binding to DNA. Chem. Biol. Interact. 125 3 (2000) 177-189
16. Kocisko D.A., Baron G.S., Rubenstein R., Chen J., Kuizon S., and Caughey B. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J. Virol. 77 19 (2003) 10288-10294
17. Kocisko D.A., Morrey J.D., Race R.E., Chen J., and Caughey B. Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice. J. Gen. Virol. 85 Pt 8 (2004) 2479-2483
18. LeBlanc A.C., and Roucou X. Toxicity and protection in prions. Science 301 5630 (2003) 168-169
19. Marienfeld C., Tadlock L., Yamagiwa Y., and Patel T. Inhibition of cholangiocarcinoma growth by tannic acid. Hepatology 37 5 (2003) 1097-1104
20. Masel J., and Jansen V.A. The kinetics of proteinase K digestion of linear prion polymers. Proc. Biol. Sci. 266 1431 (1999) 1927-1931
21. Newnam G.P., Wegrzyn R.D., Lindquist S.L., and Chernoff Y.O. Antagonistic interactions between yeast chaperones Hsp104 and Hsp70 in prion curing. Mol. Cell. Biol. 19 2 (1999) 1325-1333
22. Ono K., Hasegawa K., Naiki H., and Yamada M. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro. Biochim. Biophys. Acta 1690 3 (2004) 193-202
23. Prusiner S.B. Prion diseases and the BSE crisis. Science 278 5336 (1997) 245-251
24. Roberts B.T., Moriyama H., and Wickner R.B. [URE3] prion propagation is abolished by a mutation of the primary cytosolic Hsp70 of budding yeast. Yeast 21 2 (2004) 107-117
25. Ross C.A., and Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 10 Suppl. (2004) S10-S17
26. Wanker E.E., Scherzinger E., Heiser V., Sittler A., Eickhoff H., and Lehrach H. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol. 309 (1999) 375-386
27. Wickner R.B., Masison D.C., and Edskes H.K. [PSI] and [URE3] as yeast prions. Yeast 11 16 (1995) 1671-1685
28. Winklhofer K.F., Hartl F.U., and Tatzelt J. A sensitive filter retention assay for the detection of PrP(Sc) and the screening of anti-prion compounds. FEBS Lett. 503 1 (2001) 41-45